Editorial label review
Alloy side effects: bloating
Primary formulary: Estradiol (oral and patch) + oral micronized progesterone; oxybutynin ER for vasomotor symptoms
Quick answer
Bloating shows up on the FDA labels for the active ingredients Alloy prescribes — Estradiol (oral and patch) + oral micronized progesterone. This page walks through the labelled frequency ranges, what to watch for, and when to call your clinician.
What Alloy prescribes and why it matters for bloating
Alloy prescribes FDA-approved bioidentical estradiol and oral micronized progesterone, plus oxybutynin ER as a non-hormonal option for vasomotor symptoms. Because Alloy prescribes FDA-approved active ingredients, the labelled adverse-reaction tables from those medications describe the frequencies you should expect. Bloating is a labelled reaction on progesterone (Prometrium) and combination estradiol PILs used by all four brands.
Common label-level side effects
Sourced from Section 6 (Adverse Reactions) of each FDA-approved PIL.
- "Abdominal distension" and "bloating" are listed at 5–15% across estradiol-progestin combination PILs Section 6 tables
- Prometrium PIL Section 6.1 explicitly lists abdominal bloating at 8%
- Fezolinetant (Veozah) PIL lists abdominal pain and diarrhea at low frequency in Section 6
Serious label-level warnings
Drawn from Section 5 (Warnings and Precautions) of the FDA-approved PILs — including the estradiol boxed warning where applicable.
- Bloating paired with severe abdominal pain or jaundice — hepatic adverse-event signal on estradiol and Prometrium labels
- Bloating with rectal bleeding or persistent vomiting — evaluate urgently for gastrointestinal cause independent of HRT
When to contact your clinician
Call your clinician for bloating paired with severe pain, jaundice, or rectal bleeding — the estradiol PIL flags these as urgent.
Call 911 if you develop chest pain, one-sided weakness, sudden severe headache, vision or speech change, or shortness of breath — per the estradiol PIL boxed warning for cardiovascular events.
What to ask your provider
- “Which SKU in the Alloy formulary am I on, and what is its labelled frequency for bloating?”
- “Is my bloatinglikely a labelled adverse reaction, or something separate that needs its own workup?”
- “Would a different delivery route (patch vs. pill, oral vs. transdermal) change my expected frequency?”
- “What is the plan if bloatingdoes not settle within 2–3 cycles?”
Related editorial reading
- Full editorial review of Alloy — formulary, pricing, and clinician model.
- Is bloating caused by menopause itself? — how the transition presents on its own.
- Estradiol medication page — mechanism, dosing, and full PIL notes.
- Progesterone medication page — secondary ingredient in Alloy's formulary.
- Browse all side-effect matrix pages — 4 brands × 15 symptoms.
Frequently asked questions
- How often does bloating happen on Alloy?
- Alloy's primary regimen — Estradiol (oral and patch) + oral micronized progesterone; oxybutynin ER for vasomotor symptoms — carries the FDA-labelled adverse-reaction frequencies for bloating described on this page. Ranges vary from < 1% to 45% depending on the specific active ingredient and delivery route. See the sources block for the exact PIL tables.
- When should I stop Alloy because of bloating?
- Talk to your clinician immediately if you meet any of the "when to contact" criteria on this page — most estradiol PIL Section 5 warnings require prompt reassessment. Do not stop hormone therapy without medical input; abrupt discontinuation can trigger rebound symptoms.
- Is bloating on the FDA label for Alloy's medications?
- Bloating is a labelled reaction on progesterone (Prometrium) and combination estradiol PILs used by all four brands.
- Is bloating caused by menopause itself?
- Bloating can appear during the menopause transition for reasons unrelated to hormone therapy. Our /does-menopause-cause/bloating explainer covers what the underlying biology is and how clinicians disentangle the transition from the treatment.